Ceryvyn Therapeutics Limited (ASX:CYV)
Australia · Delayed Price · Currency is AUD 0.0130
0.00 (0.00%)
Oct 9, 2026, 4:12 PM AEST
Ceryvyn Therapeutics Market Cap
Ceryvyn Therapeutics has a market cap or net worth of 17.78 million as of October 9, 2026. It is the 40,404th most valuable company in the world and the 1,138th biggest in Australia. Its market cap has decreased by 97.59% in one year.
Market Cap
17.78M
Enterprise Value
-12.24M
Revenue
1.00K
Global Rank
Country Rank
#1,138 Australia
PE Ratio
0.05
ChartMarket Cap Chart
Since May 13, 1996, Ceryvyn Therapeutics's market cap has decreased from 39.30M to 17.78M, a decrease of -54.75%. That is a compound annual growth rate of -2.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 17.78M | -98.22% |
| Dec 31, 2024 | 997.31M | 163.98% |
| Dec 29, 2023 | 377.80M | -11.57% |
| Dec 30, 2022 | 427.23M | -6.26% |
| Dec 31, 2021 | 455.76M | -29.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 21.69M |
| Imugene | 21.06M |
| Proteomics International Laboratories | 20.67M |
| Algorae Pharmaceuticals | 18.25M |
| Noxopharm | 18.13M |
| Patrys | 18.05M |
| EZZ Life Science Holdings | 17.42M |
| Argenica Therapeutics | 16.70M |